Menu Back toDay1-Session-1-Addressing-the-Global-Impact-of-Infectious-Diseases

Accelerating Access to Innovative Products – Improving Responses to Pandemic Diseases

Day1: Session 1: Addressing the Global Impact of Infectious Diseases

Session Chair(s)

Silke  Vogel, PhD

Silke Vogel, PhD

  • Deputy Director, Center of Regulatory Excellence (CoRE); Associate Dean
  • Duke NUS , Singapore


Lee Tau Hong

Day1: S1.1: Evolving Tropical Infectious Diseases – Challenges to Treatment Management

Lee Tau Hong

  • Associate Consultant
  • Tan Tock Seng Hospital, Singapore
Hiromichi  Shirasawa, MD

Day1: S1.2: Role of the industry – Current Challenges in Meeting needs of Infectious Diseases/ Sustaining a Market for Niche Diseases

Hiromichi Shirasawa, MD

  • Vice President and Executive Officer, Head of Japan Development
  • MSD K.K., Japan

Contact us